The use of long-acting injectables in early-phase schizophrenia - Authors' reply
Publication date
2023-07
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Antipsychotic Agents/therapeutic use, Humans, Injections, Schizophrenia/drug therapy, Taverne, Letter
Citation
Fleischhacker, W W, Winter-van Rossum, I & Kahn, R S 2023, 'The use of long-acting injectables in early-phase schizophrenia - Authors' reply', The Lancet. Psychiatry, vol. 10, no. 7, pp. 482-483. https://doi.org/10.1016/S2215-0366(23)00182-7